Use of nicotine replacement after a smoking lapse

Nicotine and Tobacco Research

Volumn 14, Issue 6, 2012, Pages 751-754

  Hughes, John R ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL PROTOCOL; DRUG TREATMENT FAILURE; E-MAIL; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE;

EID: 84861545849     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntr208     Document Type: Article

References (22)

1. Abrams, D. B., Niaura, R., Brown, R. A., Emmons, K. M., Goldstein, M. G., & Monti, P. M. (2003). The tobacco dependence treatment handbook. A guide to best practices. New York, NY: The Guiford Press.
2. Benowitz, N., & Pinney, J. (1999). Nicotine preparations in smoking. In H. Korting & M. Schafer-Korting (Eds.), The benefit/risk ratio: A handbook for the rational use of potentially hazardous drugs (pp. 307-318), Boca Raton, FL: CRC Press.
3. Cokkinides, V. E., Ward, E., Jemel, A., & Thun, M. J. (2005). Under-use of smoking-cessation treatments: Results from the National Health Interview Survey, 2000. American Journal of Preventive Medicine, 28, 119-122. doi:10.1016/j.amepre.2004.09.007
4. Etter, J. (2006). A list of the most popular smoking cessation web sites and a comparison of their quality. Nicotine & Tobacco Research, 8, S27-S34. doi:10.1080/14622200601039923
5. Ferguson, S., Gitchell, J., Shiffman, S., & Sembower, M. (2009). Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: Secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers. Clinical Therapeutics, 31, 1957-1965. doi:10.1016/j.clinthera.2009.08.029
6. Fiore, M., Jaen, C., Baker, T., Bailey, W., Benowitz, N., Curry, S., et al. (2008). Treating tobacco use and dependence: Clinical practice guideline. Washington, DC: U.S. Public Health and Human Services.
7. Hughes, J. R., & Carpenter, M. J. (2005). The feasibility of reduced smoking: An update. Addiction, 100, 1074-1089. doi:10.1111/j.1360-0443.2005.01174.x
8. Japuntich, S., Piper, M., Leventhal, A., Bolt, D., & Baker, T. (2011). The effect of five smoking cessation pharmacotherapies on smoking cessation milestones. Journal of Consulting and Clinical Psychology, 79, 34-42. doi:10.1037/a0022154
9. Kleber, H. D., Weiss, R. D., Anton, R. F., Jr., George, T. P., Greenfield, S. F., Kosten, T. R., et al. (2006). Practice guideline for the treatment of patients with substance use disorders (2nd Ed.). Washington, DC: American Psychiatric Press.
10. Kozlowski, L., Giovino, G., Edwards, B., DiFranza, J., Foulds, J., Hurt, R., et al. (2007). Advice on using over-the-counter nicotine replacement therapy-patch, gum, or lozenge-to quit smoking. Addictive Behaviors, 32, 2140-2150. doi:10.1016/j.addbeh.2007.01.030
11. McEwen, A., & West, R. (1999). How to intervene against smoking. Journal of the Royal College of Physicians of London, 33, 513-515.
12. McNeill, A., Foulds, J., & Bates, C. (2001). Regulation of nicotine replacement therapies (NRT): A critique of current practice. Addiction, 96, 1757-1768. doi:10.1080/09652140120089508
13. Perkins, K., Fonte, C., Meeker, J., White, W., & Wilson, A. (2001). The discriminative stimulus and reinforcing effects of nicotine in humans following nicotine pretreatment. Behavioural Pharmacology, 12, 35-44.
14. Rose, J. E., & Behm, F. M. (2004). Extinguishing the rewarding value of smoke cues: Pharmacological and behavioral treatments. Nicotine & Tobacco Research, 6, 523-532. doi:10.1080/14622200410001696501
15. Shiffman, S., Brockwell, S. E., Pillitteri, J. L., & Gitchell, J. G. (2008). Use of smoking-cessation treatments in the United States. American Journal of Preventive Medicine, 34, 102-111. doi:10.1016/j.amepre.2007.09.033
16. Shiffman, S., & Ferguson, S. G. (2008). Nicotine patch therapy prior to quitting smoking: A meta-analysis. Addiction, 103, 557-563. doi:10.1111/j.1360-0443.2008.02138.x
17. Shiffman, S., Ferguson, S. G., Rohay, J., & Gitchell, J. G. (2008). Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: Relationship with use and compliance. Addiction, 103, 1371-1378. doi:10.1111/j.1360-0443.2008.02268.x
18. Shiffman, S., Scharf, D., Shadel, W., Gwaltney, C., Dang, Q., Paton, S., et al. (2006). Analyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers. Journal of Consulting and Clinical Psychology, 74, 276-285. doi:10.1037/0022-006X.74.2.276
19. Stead, L., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008). Nicotine replacement therapy for smoking cessation. The Cochrane Library. Retrieved from www.thecochranelibrary.com
20. West, R., & Shiffman, S. (2001). Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: A systematic review. Psychopharmacology, 155, 115-122. doi:10.1007/s002130100712
21. Zapawa, L. M., Hughes, J., Benowitz, N., Rigotti, N., & Shiffman, S. (2011). Cautions and warnings on the US OTC label for nicotine replacement: What's a doctor to do? Addictive Behaviors, 36, 327-332. doi:10.1016/j.addbeh.2010.12.003
22. Zevin, S., Jacob III, P., & Benowitz, N. (1998). Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clinical Pharmacology and Therapeutics, 64, 87-95. doi:10.1016/S0009-9236(98)90026-1